-
MiniMed Group (MMED) Reiterated at Buy by StoneX Ahead of Q1 Earnings
-
MiniMed ships its Flex pump with Abbott's Instinct sensor in the U.S.
-
MiniMed Group (MMED) PT Raised to $24 at BofA Securities
-
UBS Starts MiniMed Group (MMED) at Buy
-
Benchmark Reiterates Buy Rating on MiniMed Group (MMED)
-
MiniMed launches Abbott Instinct sensors in Europe for its insulin systems
-
MiniMed Group (MMED) Reiterated at Buy by Benchmark After ADA Meeting
-
Benchmark Reiterates Buy Rating on MiniMed Group (MMED) Following Better-Than-Expected Q4
-
Piper Sandler on MiniMed Group (MMED): 'Nice Start as a Public Entity but Still Plenty to Prove'
-
MiniMed partners with Abbott for dual glucose-ketone sensors
-
MiniMed receives Health Canada license for diabetes system update
-
Q1 MedTech quarterly preview: BTIG
-
Deutsche Bank Starts MiniMed Group (MMED) at Buy
-
Goldman Sachs Starts MiniMed Group (MMED) at Buy
-
William Blair Starts MiniMed Group (MMED) at Outperform
-
Evercore ISI Starts MiniMed Group (MMED) at Outperform
-
BTIG Reiterates Buy Rating on MiniMed Group (MMED)
-
Wells Fargo Starts MiniMed Group (MMED) at Overweight
-
Mizuho Starts MiniMed Group (MMED) at Outperform
-
Morgan Stanley Starts MiniMed Group (MMED) at Overweight
-
Citi Starts MiniMed Group (MMED) at Buy
-
Piper Sandler Starts MiniMed Group (MMED) at Neutral
-
MiniMed receives FDA clearance for smartphone-controlled insulin pump
-
MiniMed begins trading on NASDAQ Global Select Market after IPO
-
MiniMed Group (MMED) files for proposed Nasdaq IPO
-
MiniMed Group (MMED) files for proposed IPO

